We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
CKB
SECTIONS
  • TISSUE
  • BRAIN
  • SINGLE CELL TYPE
  • TISSUE CELL TYPE
  • PATHOLOGY
  • DISEASE
  • IMMUNE CELL
  • BLOOD PROTEIN
  • SUBCELLULAR
  • CELL LINE
  • STRUCTURE
  • INTERACTION
ABOUT
  • INTRODUCTION
  • HISTORY
  • ORGANIZATION
  • PUBLICATIONS
  • ANTIBODY SUBMISSION
  • ANTIBODY AVAILABILITY
  • ACKNOWLEDGMENTS
  • CONTACT
NEWS
  • NEWS ARTICLES
  • PRESS ROOM
LEARN
  • DICTIONARY
  • PROTEIN CLASSES
  • PROTEIN EVIDENCE
  • METHODS
  • EDUCATIONAL VIDEOS
DATA
  • DOWNLOADABLE DATA
  • PUBLICATION DATA
  • RELEASE HISTORY
  • SARS-COV-2
HELP
  • ANTIBODY VALIDATION
  • ASSAYS & ANNOTATION
  • DISCLAIMER
  • HELP & FAQ
  • PRIVACY STATEMENT
  • LICENCE & CITATION
Fields »
Search result

Field
Term
Gene name
Class
Subclass
Class
Keyword
Chromosome
External id
Tissue
Cell type
Expression
Patient ID
Tissue
Category
Cluster
Reliability
Brain region
Category
Brain region
Category
Brain region
Category
Cluster
Reliability
Cell type
Category
Cluster
Tissue
Cell type
Enrichment
Cancer
Prognosis
Cancer
Category
Cell type
Category
Cell lineage
Category
Cluster
Annotation
Disease
Location
Searches
Location
Cell line
Type
Phase
Reliability
Cancer type
Category
Cluster
Interacting gene
Number of interactions
Pathway
Category
Score
Score
Score
Validation
Validation
Validation
Validation
Antibodies
Protein structure
In atlas
Column


  • SUMMARY

  • TISSUE

  • BRAIN

  • SINGLE CELL

  • TISSUE CELL

  • PATHOLOGY

  • DISEASE

  • IMMUNE

  • BLOOD

  • SUBCELL

  • CELL LINE

  • STRUCTURE

  • INTERACTION

  • CKB
PATHOLOGY GLIOMA Show tissue menu
BREAST CANCER CARCINOID CERVICAL CANCER COLORECTAL CANCER ENDOMETRIAL CANCER GLIOMA HEAD AND NECK CANCER LIVER CANCER LUNG CANCER LYMPHOMA
MELANOMA OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER RENAL CANCER SKIN CANCER STOMACH CANCER TESTIS CANCER THYROID CANCER UROTHELIAL CANCER
ANTIBODIES
AND
VALIDATION
Dictionary
Glioma
Human pathology
Glioma
GLIOMA - Interactive survival scatter ploti

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisi

Kaplan-Meier plots summarize results from analysis of correlation between mRNA expression level and patient survival. Patients were divided based on level of expression into one of the two groups "low" (under cut off) or "high" (over cut off). X-axis shows time for survival (years) and y-axis shows the probability of survival, where 1.0 corresponds to 100 percent.

CKB is not prognostic in glioma


Stage:
Survival analysis
Current cut offi

Current cut-off shows the cut-off (FPKM) currently selected. It may be changed manually. When the current cut-off is changed, the vertical dashed line indicating cut-off, the interactive survival scatter plot and the Kaplan-Meier curve will be automatically adjusted to show results accordingly.

:
Best expression cut offi

Based on the FPKM value of each gene, patients were classified into two groups and association between prognosis (survival) and gene expression (FPKM) was examined. The best expression cut-off refers the FPKM value that yields maximal difference with regard to survival between the two groups at the lowest log-rank P-value. Best expression cut-off was selected based on survival analysis .

When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the best expression cut-off.

: 261.3
Median expressioni

Median expression refers to the median FPKM value calculated based on the gene expression (FPKM) data from all patients in this dataset. When clicking on this number, the vertical dashed line indicating cut-off, the interactive survival plot, and the Kaplan-Meier curve will be adjusted to show results based on the median expression.

: N/A
Median follow up timei

Median follow up time refers to the median time (years) after diagnosis with this type of cancer, based on clinical data from all patients in this dataset.

: N/A
P scorei

Log-rank P value for Kaplan-Meier plot showing results from analysis of correlation between mRNA expression level and patient survival.

N/A
3-year survival highi

5-year survival for patients with higher expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
3-year survival lowi

5-year survival for patients with lower expression than the expression cutoff.

For melanoma and glioma, 3-year survival is shown.

N/A
TCGA RNA samplesi

RNA-seq data is reported as average FPKM (number Fragments Per Kilobase of exon per Million reads), generated by the The Cancer Genome Atlas (TCGA) .

Normal distribution across the dataset is visualized with box plots, shown as median and 25th and 75th percentiles. Points are displayed as outliers if they are above or below 1.5 times the interquartile range. FPKM values of the individual samples are presented next to the box plot.

Average FPKM 295.8
Number of samples 153
Samples
Sample Description FPKM
TCGA-06-0747-01A 53 years, male, white, dead, 82 days 1122.4
TCGA-12-1597-01B 62 years, female, white, dead, 675 days 718.5
TCGA-41-2572-01A 67 years, male, white, dead, 406 days 707.2
TCGA-41-5651-01A 59 years, female, black or african american, dead, 460 days 684.5
TCGA-12-0618-01A 49 years, male, white, dead, 395 days 682.1
TCGA-02-2485-01A 53 years, male, black or african american, alive, 470 days 633.0
TCGA-12-3652-01A 60 years, male, white, dead, 1062 days 631.5
TCGA-19-2624-01A 51 years, male, white, dead, 5 days 631.3
TCGA-19-2620-01A 70 years, male, white, dead, 148 days 630.3
TCGA-14-0790-01B 64 years, female, white, dead, 419 days 621.0
TCGA-06-0749-01A 50 years, male, black or african american, dead, 82 days 614.6
TCGA-26-5139-01A 65 years, female, white, alive, 48 days 590.3
TCGA-27-2521-01A 34 years, male, white, dead, 510 days 585.2
TCGA-06-0743-01A 69 years, male, white, dead, 803 days 575.5
TCGA-15-0742-01A 65 years, male, white, dead, 419 days 570.3
TCGA-32-2634-01A 82 years, male, white, alive, 693 days 560.4
TCGA-06-0157-01A 63 years, female, white, dead, 97 days 544.6
TCGA-08-0386-01A 74 years, male, white, dead, 548 days 529.3
TCGA-19-2625-01A 76 years, female, white, dead, 124 days 524.7
TCGA-12-3650-01A 46 years, male, white, dead, 333 days 523.4
TCGA-12-3653-01A 34 years, female, white, dead, 442 days 517.6
TCGA-27-1835-01A 53 years, female, white, dead, 648 days 506.7
TCGA-06-2563-01A 72 years, female, white, alive, 932 days 505.1
TCGA-06-0686-01A 53 years, male, white, dead, 432 days 480.3
TCGA-76-4925-01A 76 years, male, white, dead, 146 days 477.3
TCGA-06-0211-01B 47 years, male, white, dead, 360 days 462.9
TCGA-19-2619-01A 55 years, female, black or african american, alive, 294 days 452.7
TCGA-27-2528-01A 62 years, male, white, dead, 480 days 452.2
TCGA-28-2514-01A 45 years, male, asian, alive, 160 days 450.4
TCGA-06-0744-01A 67 years, male, white, dead, 1426 days 444.1
TCGA-76-4932-01A 50 years, female, white, dead, 1458 days 440.8
TCGA-06-0174-01A 54 years, male, white, dead, 98 days 414.4
TCGA-06-0125-01A 63 years, female, white, dead, 1448 days 411.9
TCGA-27-2526-01A 79 years, female, white, dead, 87 days 405.5
TCGA-32-1970-01A 59 years, male, white, dead, 468 days 398.9
TCGA-28-1747-01C 44 years, male, white, dead, 77 days 396.0
TCGA-19-2629-01A 60 years, male, white, dead, 737 days 394.8
TCGA-76-4931-01A 70 years, female, white, dead, 279 days 387.7
TCGA-32-2632-01A 80 years, male, white, dead, 269 days 384.8
TCGA-15-1444-01A 21 years, male, white, dead, 1537 days 384.0
TCGA-76-4926-01B 68 years, male, white, dead, 138 days 372.5
TCGA-02-2483-01A 43 years, male, asian, alive, 466 days 366.7
TCGA-06-5858-01A 45 years, female, white, alive, 187 days 365.1
TCGA-06-0238-01A 46 years, male, white, dead, 405 days 359.0
TCGA-14-0787-01A 69 years, male, asian, dead, 68 days 353.8
TCGA-41-2571-01A 89 years, male, white, dead, 26 days 352.0
TCGA-06-2559-01A 83 years, male, white, dead, 150 days 351.7
TCGA-06-0882-01A 30 years, male, white, dead, 632 days 349.4
TCGA-06-0158-01A 73 years, male, white, dead, 329 days 347.0
TCGA-06-0187-01A 69 years, male, white, dead, 828 days 346.8
TCGA-32-4213-01A 47 years, female, white, alive, 604 days 346.5
TCGA-06-2558-01A 75 years, female, white, dead, 380 days 320.4
TCGA-06-2557-01A 76 years, male, black or african american, dead, 33 days 316.0
TCGA-27-2523-01A 63 years, male, white, dead, 489 days 314.6
TCGA-26-5136-01B 78 years, female, white, dead, 577 days 310.9
TCGA-28-5208-01A 52 years, male, white, dead, 544 days 310.1
TCGA-06-0184-01A 63 years, male, white, dead, 2126 days 308.1
TCGA-26-5133-01A 59 years, male, white, alive, 452 days 307.8
TCGA-28-2499-01A 59 years, male, white, dead, 95 days 306.8
TCGA-28-5209-01A 66 years, female, white, alive, 77 days 299.3
TCGA-26-5135-01A 72 years, female, white, dead, 270 days 298.7
TCGA-14-1825-01A 70 years, male, white, dead, 232 days 298.3
TCGA-16-0846-01A 85 years, male, white, dead, 119 days 298.0
TCGA-32-5222-01A 66 years, male, white, dead, 585 days 297.2
TCGA-06-5408-01A 54 years, female, white, dead, 357 days 294.9
TCGA-06-0132-01A 49 years, male, white, dead, 771 days 291.6
TCGA-19-5960-01A 56 years, male, white, dead, 455 days 289.6
TCGA-14-1034-01A 60 years, female, dead, 485 days 288.8
TCGA-27-1837-01A 36 years, male, white, dead, 427 days 283.6
TCGA-19-1787-01B 49 years, male, white, dead, 385 days 281.1
TCGA-06-0219-01A 67 years, male, white, dead, 22 days 278.3
TCGA-41-4097-01A 63 years, female, white, dead, 6 days 274.7
TCGA-28-1753-01A 53 years, male, white, alive, 37 days 274.3
TCGA-32-1980-01A 72 years, male, white, dead, 36 days 273.3
TCGA-02-0047-01A 78 years, male, white, dead, 448 days 272.7
TCGA-06-2570-01A 21 years, female, white, alive, 958 days 270.2
TCGA-06-0178-01A 39 years, male, white, dead, 2681 days 269.8
TCGA-76-4927-01A 58 years, male, white, dead, 535 days 267.0
TCGA-06-5418-01A 75 years, female, white, dead, 83 days 266.7
TCGA-32-2638-01A 67 years, male, white, dead, 766 days 266.2
TCGA-06-5414-01A 61 years, male, white, alive, 273 days 263.5
TCGA-06-0129-01A 30 years, male, asian, dead, 1024 days 262.7
TCGA-06-5411-01A 51 years, male, white, dead, 254 days 259.9
TCGA-12-5299-01A 56 years, female, white, dead, 98 days 258.9
TCGA-12-0619-01A 60 years, male, white, dead, 1062 days 256.5
TCGA-41-3915-01A 48 years, male, white, dead, 360 days 256.3
TCGA-06-0168-01A 59 years, female, white, dead, 598 days 254.1
TCGA-32-2616-01A 48 years, female, white, dead, 224 days 246.0
TCGA-27-2524-01A 56 years, male, white, dead, 231 days 242.2
TCGA-28-5220-01A 67 years, male, white, dead, 388 days 238.3
TCGA-76-4929-01A 76 years, female, white, dead, 111 days 235.1
TCGA-06-2567-01A 65 years, male, white, dead, 133 days 232.7
TCGA-28-5207-01A 71 years, male, white, dead, 343 days 229.6
TCGA-06-5856-01A 58 years, male, white, dead, 114 days 227.0
TCGA-14-0817-01A 69 years, female, white, dead, 164 days 226.2
TCGA-06-1804-01A 81 years, female, white, dead, 414 days 219.4
TCGA-06-0649-01B 73 years, female, black or african american, dead, 64 days 218.3
TCGA-06-0745-01A 59 years, male, white, dead, 239 days 210.4
TCGA-06-5413-01A 67 years, male, white, alive, 268 days 210.3
TCGA-06-2564-01A 50 years, male, white, alive, 181 days 207.9
TCGA-26-1442-01A 43 years, male, white, alive, 953 days 207.9
TCGA-32-1982-01A 76 years, female, white, dead, 142 days 207.6
TCGA-26-5132-01A 74 years, male, white, alive, 286 days 205.2
TCGA-28-5204-01A 72 years, male, white, dead, 454 days 197.0
TCGA-06-5417-01A 45 years, female, white, alive, 155 days 186.4
TCGA-06-2565-01A 59 years, male, asian, dead, 506 days 180.4
TCGA-06-0210-01A 72 years, female, white, dead, 225 days 180.1
TCGA-12-0821-01A 62 years, male, white, dead, 323 days 178.3
TCGA-06-2561-01A 53 years, female, white, dead, 537 days 176.7
TCGA-06-0645-01A 56 years, female, white, dead, 175 days 174.8
TCGA-06-0138-01A 43 years, male, white, dead, 737 days 174.2
TCGA-28-5215-01A 62 years, female, white, dead, 335 days 172.0
TCGA-28-5216-01A 52 years, male, white, alive, 415 days 171.3
TCGA-06-5416-01A 23 years, female, white, alive, 204 days 170.3
TCGA-32-2615-01A 62 years, male, white, dead, 485 days 162.5
TCGA-27-1834-01A 56 years, male, white, dead, 1233 days 159.3
TCGA-14-1829-01A 57 years, male, black or african american, alive, 218 days 158.7
TCGA-14-2554-01A 52 years, female, white, dead, 532 days 155.8
TCGA-27-1830-01A 57 years, male, white, dead, 154 days 154.9
TCGA-12-0616-01A 36 years, female, white, dead, 448 days 152.6
TCGA-06-5412-01A 78 years, female, white, dead, 138 days 152.5
TCGA-19-1390-01A 63 years, female, white, dead, 772 days 150.8
TCGA-12-5295-01A 60 years, female, white, dead, 454 days 149.0
TCGA-19-4065-01A 36 years, male, white, alive, 214 days 142.0
TCGA-14-0781-01B 49 years, male, black or african american, dead, 29 days 140.0
TCGA-06-0750-01A 43 years, male, white, dead, 28 days 136.8
TCGA-26-5134-01A 74 years, male, white, alive, 167 days 133.7
TCGA-27-1831-01A 66 years, male, white, dead, 505 days 132.2
TCGA-06-5859-01A 63 years, male, white, alive, 139 days 130.4
TCGA-06-5410-01A 72 years, female, white, dead, 108 days 128.3
TCGA-06-0141-01A 62 years, male, white, dead, 313 days 126.4
TCGA-06-0646-01A 61 years, male, white, dead, 175 days 125.6
TCGA-28-2509-01A 77 years, female, white, alive, 145 days 125.4
TCGA-27-1832-01A 59 years, female, white, dead, 300 days 113.6
TCGA-06-0190-01A 62 years, male, white, dead, 317 days 111.1
TCGA-06-0878-01A 74 years, male, white, alive, 218 days 110.5
TCGA-16-1045-01B 49 years, female, white, dead, 883 days 110.2
TCGA-06-0156-01A 57 years, male, white, dead, 178 days 107.0
TCGA-28-2513-01A 69 years, female, white, alive, 222 days 102.9
TCGA-27-2519-01A 48 years, male, white, dead, 550 days 99.8
TCGA-06-2562-01A 81 years, male, white, dead, 382 days 97.4
TCGA-76-4928-01B 85 years, female, white, dead, 94 days 94.1
TCGA-14-0789-01A 54 years, male, white, dead, 342 days 80.7
TCGA-28-5213-01A 72 years, male, white, alive, 951 days 73.8
TCGA-02-2486-01A 64 years, male, white, dead, 618 days 69.1
TCGA-14-0871-01A 75 years, female, white, dead, 880 days 55.5
TCGA-06-0139-01A 40 years, male, white, dead, 362 days 51.8
TCGA-14-1823-01A 58 years, female, white, dead, 543 days 47.6
TCGA-06-0644-01A 71 years, male, black or african american, dead, 384 days 35.9
TCGA-02-0055-01A 62 years, female, white, dead, 76 days 34.8
TCGA-06-2569-01A 24 years, female, black or african american, alive, 13 days 19.3
TCGA-06-0130-01A 54 years, male, white, dead, 394 days 7.1
TCGA-28-5218-01A 63 years, male, white, dead, 157 days 4.3
Show allShow less
GLIOMA - Protein expressioni

A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here.

Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

 

Antibody stainingi

Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells.

Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.


Antibody HPA001254

Antibody CAB047313
 Staining
  High
  Medium
  Low
  Not detected
 Intensity
  Strong
  Moderate
  Weak
  Negative
 Quantity
  >75%
  75%-25%
  <25%
  None
 Location
  Nuclear
  Cytoplasmic/membranous
  Cytoplasmic/membranous,nuclear
  None
Click images for details

Contact

  • NEWS ARTICLES
  • PRESS ROOM

The Project

  • INTRODUCTION
  • ORGANIZATION
  • PUBLICATIONS

The Human Protein Atlas

  • DOWNLOADABLE DATA
  • LICENCE & CITATION
  • HELP & FAQ
The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg Foundation.


contact@proteinatlas.org